SCRI’s contract research organization: the premier partner of choice

 
 

SCRI Logo

The contract research organization (CRO) model of today requires an ever-evolving approach to address increasing demands – from FDA requirements for diversity plans for clinical trial participation to growing requests for supporting efficient clinical trial design and the availability of high-quality data for rapid analysis – all while maintaining the goal of producing clinically meaningful results.

Learn about how SCRI Development Innovations is uniquely positioned to make an impact.

 
 

Optimizing the CRO model to address the industry’s ever-changing landscape

 

SCRI Development Innovations, our global, full-service CRO, offers end-to-end capabilities fully dedicated to oncology – from first-in-human studies to regulatory approval. Our patients are at the center of every decision we make. We have a long history and proven track record of partnering with biopharma companies to design, manage and monitor Phase 1 through Phase 4 clinical trials and analyze the results to advance therapies for people facing cancer.

SCRI Development Innovations leverages the expertise of globally recognized oncologists to design and implement clinical trials.

Through Accelero, we work in tandem with our centralized Site Management Organization (SMO) to design and deliver timely site activation, patient recruitment and overall study delivery. This enhanced collaboration enables efficiencies that accelerate drug development and optimize clinical trial operations.

Our Personalized Medicine program, powered by precision medicine technology from Genospace, offers scientific consultative services to our biopharma partners to inform clinical development approaches every step of the way and enrich clinical development insights.

 

We have been providing CRO services in oncology since 2006.

 

Our roots are in cancer. With our network of affiliated community-based clinical trial sites at more than 250 locations in 24 states in the U.S. with more than 1,300 research physicians enrolling patients in clinical trials, we are able to leverage our existing strategic relationships and infrastructure to expedite the start-up of clinical trials in as few as six weeks. We also have unique capabilities in personalized medicine and data.

 

Proven performance

 
  • 395+ trials conducted to date, including both industry-sponsored and investigator-initiated trials 
  • 70+ first-in-human trials conducted 
  • 25+ first-in-class trials conducted 

Optimizing the CRO model to address the industry’s ever-changing landscape

 

SCRI Development Innovations, our global, full-service CRO, offers end-to-end capabilities fully dedicated to oncology – from first-in-human studies to regulatory approval. Our patients are at the center of every decision we make. We have a long history and proven track record of partnering with biopharma companies to design, manage and monitor Phase 1 through Phase 4 clinical trials and analyze the results to advance therapies for people facing cancer.

SCRI Development Innovations leverages the expertise of globally recognized oncologists to design and implement clinical trials.

Through Accelero, we work in tandem with our centralized Site Management Organization (SMO) to design and deliver timely site activation, patient recruitment and overall study delivery. This enhanced collaboration enables efficiencies that accelerate drug development and optimize clinical trial operations.

Our Personalized Medicine program, powered by precision medicine technology from Genospace, offers scientific consultative services to our biopharma partners to inform clinical development approaches every step of the way and enrich clinical development insights.

 

We have been providing CRO services in oncology since 2006.

 

Our roots are in cancer. With our network of affiliated community-based clinical trial sites at more than 250 locations in 24 states in the U.S. with more than 1,300 research physicians enrolling patients in clinical trials, we are able to leverage our existing strategic relationships and infrastructure to expedite the start-up of clinical trials in as few as six weeks. We also have unique capabilities in personalized medicine and data.

 

Proven performance

 
  • 395+ trials conducted to date, including both industry-sponsored and investigator-initiated trials 
  • 70+ first-in-human trials conducted 
  • 25+ first-in-class trials conducted 
 
 
 
 

We have proven expertise in numerous areas of oncology research

 

Biopharma partners have access to our full scope of CRO services:

 
  • Clinical development: Our expert scientists manage clinical data throughout a study's lifecycle. They advance therapeutic assets from concept to clinical development, identify target patient profiles, consult key opinion leaders, and enhance trial efficiencies. 

  • Medical monitoring: Our team of medical professionals and experienced oncology physicians ensures the successful implementation and maintenance of safety strategies and processes. They handle enrollment approval, address protocol and site questions, and provide input on safety requirements for drug development across all oncologic areas and trial phases. 

  • Medical writing and publishing: With nearly four decades of clinical trial experience, our team authors essential documents for drug development, including protocols, consent forms, regulatory submissions, scientific publications, and patient educational materials. 

  • Pharmacovigilance: Our expert team of safety leads, scientists and physicians ensures patient safety with customizable solutions, including Safety Monitoring Plans, Oracle Argus database, case processing, ongoing safety data review, signal detection, and periodic safety reports (DSUR). 

  • Regulatory affairs: With over 30 years of experience, our team handles authority and IRB submissions for clinical trials in the U.S., Canada, and the U.K. 

  • Strategic planning and oversight: Our cross-functional teams will collaborate to plan an efficient method for executing your trial. We'll anticipate and mitigate study challenges, maintaining a nimble approach for rapid decision-making to achieve your milestones. 

  • Global clinical monitoring: Our clinical monitoring team, comprising trained clinical research associates with oncology and early phase expertise, conducts remote and on-site visits across North America and globally. Experienced in 100% and reduced SDV models, our CRAs oversee data integrity, manage sites, and support regulatory compliance to produce high-quality data. 

  • Data management and biostatistics: Our team offers services during start-up, maintenance, and close-out. At each phase, our experienced team follows rigorous processes to provide quality data management and biostatistics services, ensuring clean data, continuous review, regulatory compliance, and final deliverables for our sponsors. 

  • Project management: Our Clinical Affairs team collaborates with participating sites to ensure a smooth and seamless study experience, while our Project Managers ensure all the moving parts of the study come together for an efficient and cohesive experience for our patients.
 
 

We have proven expertise in numerous areas of oncology research

 

Biopharma partners have access to our full scope of CRO services:

 
  • Clinical development: Our expert scientists manage clinical data throughout a study's lifecycle. They advance therapeutic assets from concept to clinical development, identify target patient profiles, consult key opinion leaders, and enhance trial efficiencies. 

  • Medical monitoring: Our team of medical professionals and experienced oncology physicians ensures the successful implementation and maintenance of safety strategies and processes. They handle enrollment approval, address protocol and site questions, and provide input on safety requirements for drug development across all oncologic areas and trial phases. 

  • Medical writing and publishing: With nearly four decades of clinical trial experience, our team authors essential documents for drug development, including protocols, consent forms, regulatory submissions, scientific publications, and patient educational materials. 

  • Pharmacovigilance: Our expert team of safety leads, scientists and physicians ensures patient safety with customizable solutions, including Safety Monitoring Plans, Oracle Argus database, case processing, ongoing safety data review, signal detection, and periodic safety reports (DSUR). 

  • Regulatory affairs: With over 30 years of experience, our team handles authority and IRB submissions for clinical trials in the U.S., Canada, and the U.K. 

  • Strategic planning and oversight: Our cross-functional teams will collaborate to plan an efficient method for executing your trial. We'll anticipate and mitigate study challenges, maintaining a nimble approach for rapid decision-making to achieve your milestones. 

  • Global clinical monitoring: Our clinical monitoring team, comprising trained clinical research associates with oncology and early phase expertise, conducts remote and on-site visits across North America and globally. Experienced in 100% and reduced SDV models, our CRAs oversee data integrity, manage sites, and support regulatory compliance to produce high-quality data. 

  • Data management and biostatistics: Our team offers services during start-up, maintenance, and close-out. At each phase, our experienced team follows rigorous processes to provide quality data management and biostatistics services, ensuring clean data, continuous review, regulatory compliance, and final deliverables for our sponsors. 

  • Project management: Our Clinical Affairs team collaborates with participating sites to ensure a smooth and seamless study experience, while our Project Managers ensure all the moving parts of the study come together for an efficient and cohesive experience for our patients.
 
top